01.12.2015 | Research article | Ausgabe 1/2015 Open Access

Albumin rather than C-reactive protein may be valuable in predicting and monitoring the severity and course of acute respiratory distress syndrome in critically ill patients with or at risk for the syndrome after new onset fever
- Zeitschrift:
- BMC Pulmonary Medicine > Ausgabe 1/2015
Competing interests
Authors’ contributions
Background
Methods
Protocol
Biochemistry
Statistical analysis
Results
Patients
Berlin category
|
0
|
1
|
2
|
3
|
P-value
|
---|---|---|---|---|---|
N = 53
|
N = 9
|
N = 32
|
N = 7
|
||
Age, years
|
61 (30)
|
71 (22)
|
63 (24)
|
69 (29)
|
0.21
|
Sex, male
|
39 (74)
|
5 (56)
|
20 (63)
|
5 (71)
|
0.60
|
SAPS II admission
|
46 (20)
|
59 (24)
|
49 (16)
|
44 (57)
|
0.39
|
SOFA D0
|
7 (4)
|
8 (5)
|
9 (5)
|
10 (5)
|
0.06
|
ICU days until inclusion
|
6 (12)
|
7 (19)
|
8 (12)
|
9 (32)
|
0.98
|
CVP D0, mmHg
|
9 (5)
|
5 (2)
|
6 (6)
|
7 (3)
|
0.26
|
CVP D1, mmHg
|
8 (5)
|
6 (5)
|
7 (4)
|
6 (0)
|
0.83
|
CVP D2, mmHg
|
7 (4)
|
9 (2)
|
6 (4)
|
5 (0)
|
0.25
|
CVP D7, mmHg
|
7 (4)
|
9 (4)
|
7 (5)
|
9 (1)
|
0.49
|
Vasopressor use D0-7
|
28 (53)
|
6 (67)
|
23 (72)
|
5 (71)
|
0.20
|
Renal replacement therapy D0-7
|
3 (6)
|
1 (11)
|
4 (13)
|
0
|
0.57
|
Albumin 20% administration (100 mL) D0-7
|
3 (6)
|
2 (22)
|
8 (25)
|
0
|
0.03
|
Corticosteroids use D -7-0
|
23 (43)
|
5 (56)
|
14 (44)
|
3 (43)
|
0.92
|
Corticosteroid use D 0-7
|
23 (43)
|
7 (78)
|
16 (50)
|
4 (57)
|
0.28
|
28-day mortality
|
9 (17)
|
4 (44)
|
10 (31)
|
3 (43)
|
0.15
|
LIS category
|
LIS <1
|
LIS 1.0-2.5
|
LIS >2.5
|
||
N =14
|
N = 69
|
N =18
|
P-value
|
||
Age, years
|
62 (28)
|
63 (24)
|
59 (28)
|
0.92
|
|
Sex, man
|
10 (71)
|
47 (68)
|
12 (67)
|
0.96
|
|
SAPS II at admission
|
49 (20)
|
47 (20)
|
45 (23)
|
0.35
|
|
SOFA D0
|
5 (2)
|
8 (5)
|
10 (3)
|
0.004
|
|
ICU days until inclusion
|
6 (14)
|
7 (9)
|
6 (12)
|
0.85
|
|
CVP D0, mmHg
|
8 (6)
|
7 (5)
|
8 (5)
|
0.79
|
|
CVP D1, mmHg
|
7 (4)
|
7 (6)
|
7 (4)
|
0.50
|
|
CVP D2, mmHg
|
3 (0)
|
7 (3)
|
7 (6)
|
0.32
|
|
CVP D7, mmHg
|
6 (7)
|
7 (5)
|
8 (3)
|
0.61
|
|
Vasopressor use D0-7
|
5 (39)
|
4 (63)
|
14 (82)
|
0.05
|
|
Renal replacement therapy D0-7
|
0
|
7 (10)
|
1 (6)
|
0.40
|
|
Albumin 20% administration (100 mL) D 0-7
|
0
|
12 (17)
|
1 (6)
|
0.12
|
|
Corticosteroids use D -7-0
|
6 (43)
|
31 (45)
|
8 (44)
|
0.99
|
|
Corticosteroid use D 0-7
|
4 (29)
|
35 (51)
|
11 (61)
|
0.18
|
|
28-day mortality
|
2 (14)
|
18 (26)
|
6 (33)
|
0.47
|
Berlin category
|
0
|
1
|
2
|
3
|
P-value
|
---|---|---|---|---|---|
N = 53
|
N = 9
|
N = 32
|
N = 7
|
||
Ventilator course D0-7
|
|||||
Mechanical ventilation D0
|
47 (89)
|
9 (100)
|
32 (100)
|
7 (100)
|
0.12
|
duration, days
|
22 (30)
|
23 (27)
|
22 (25)
|
16 (26)
|
0.85
|
P
aO
2/F
IO
2 ratio D0
|
180 (76)
|
226 (60)
|
155 (49)
|
89 (32)
|
<0.001
|
P
aO
2/F
IO
2 ratio D1
|
191 (66)
|
208 (64)
|
156 (34)
|
91 (0)
|
<0.001
|
P
aO
2/F
IO
2 ratio D2
|
194 (105)
|
252 (41)
|
168 (35)
|
68 (0)
|
<0.001
|
P
aO2/F
IO
2 ratio D7
|
189 (110)
|
239 (23)
|
161 (48)
|
73 (21)
|
<0.001
|
PEEP D0, cmH
20
|
8 (7)
|
8 (4)
|
10 (4)
|
10 (2)
|
0.10
|
PEEP D1, cmH
20
|
8 (7)
|
8 (6)
|
10 (4)
|
13 (0)
|
0.13
|
PEEP D2, cmH
20
|
8 (7)
|
10 (6)
|
10 (4)
|
8 (0)
|
0.40
|
PEEP D7, cmH
20
|
6 (6)
|
11 (7)
|
9 (4)
|
13 (8)
|
0.001
|
Compliance D0, mL/cmH
20
|
32 (23)
|
39 (13)
|
38 (23)
|
36 (27)
|
0.88
|
Compliance D1, mL/cmH
20
|
39 (18)
|
35 (24)
|
35 (18)
|
21 (0)
|
0.24
|
Compliance D2, mL/cmH
20
|
35 (20)
|
40 (30)
|
35 (20)
|
33 (0)
|
0.78
|
Compliance D7, mL/cmH
20
|
47 (34)
|
31 (12)
|
37 (24)
|
19 (9)
|
0.11
|
Tidal volume D0, mL
|
500 (217)
|
500 (116)
|
520 (206)
|
530 (256)
|
0.92
|
Tidal volume D1, mL
|
520 (120)
|
500 (140)
|
500 (210)
|
530 (150)
|
0.68
|
Tidal volume D2, mL
|
520 (123)
|
500 (147)
|
505 (250)
|
550 (300)
|
0.78
|
Tidal volume D7, mL
|
530 (192)
|
463 (216)
|
500 (150)
|
450 (250)
|
0.17
|
Chest radiograph D0, quadrants
|
1 (1)
|
2 (0)
|
2 (1)
|
2 (1)
|
<0.001
|
Chest radiograph D1, quadrants
|
1 (1)
|
2 (0)
|
2 (1)
|
2
|
<0.001
|
Chest radiograph D2, quadrants
|
1 (1)
|
2 (1)
|
2 (1)
|
3
|
<0.001
|
Chest radiograph D7, quadrants
|
0 (1)
|
2 (0)
|
2 (2)
|
3 (1)
|
<0.001
|
LIS category
|
LIS <1
|
LIS 1.0-2.5
|
LIS >2.5
|
||
N =14
|
N = 69
|
N =18
|
P-value
|
||
Ventilator course D0-7
|
|||||
Mechanical ventilation D0
|
10 (71)
|
67 (97)
|
18 (100)
|
0.001
|
|
duration, days
|
11 (20)
|
22 (27)
|
28 (21)
|
0.07
|
|
P
aO
2/F
IO
2 ratio D0
|
214 (130)
|
174 (68)
|
112 (70)
|
<0.001
|
|
P
aO
2/F
IO
2 ratio D1
|
238 (157)
|
184 (60)
|
149 (40)
|
<0.001
|
|
P
aO
2/F
IO
2 ratio D2
|
284 (111)
|
181 (72)
|
156 (48)
|
<0.001
|
|
P
aO
2/F
IO
2 ratio D7
|
269 (162)
|
177 (79)
|
102 (78)
|
<0.001
|
|
PEEP D0, cmH
20
|
5 (2)
|
9 (6)
|
14 (3)
|
<0.001
|
|
PEEP D1, cmH
20
|
5 (1)
|
9 (4)
|
13 (4)
|
<0.001
|
|
PEEP D2, cmH
20
|
5 (1)
|
9 (5)
|
12 (6)
|
<0.001
|
|
PEEP D7, cmH
20
|
4 (3)
|
8 (6)
|
14 (5)
|
<0.001
|
|
Compliance D0, mL/cmH
20
|
44 (57)
|
39 (20)
|
27 (18)
|
<0.001
|
|
Compliance D1, mL/cmH
20
|
51 (25)
|
37 (18)
|
28 (21)
|
<0.001
|
|
Compliance D2, mL/cmH
20
|
61 (105)
|
35 (19)
|
31 (21)
|
0.01
|
|
Compliance D7, mL/cmH
20
|
65 (75)
|
37 (24)
|
20 (11)
|
0.007
|
|
Tidal volume D0, mL
|
409 (268)
|
500 (176)
|
550 (154)
|
0.39
|
|
Tidal volume D1, mL
|
523 (177)
|
500 (166)
|
523 (95)
|
0.92
|
|
Tidal volume D2, mL
|
490 (138)
|
525 (133)
|
535 (194)
|
0.43
|
|
Tidal volume D7, mL
|
450 (150)
|
500 (213)
|
500 (138)
|
0.71
|
|
Chest radiograph D0, no quadrants
|
0 (1)
|
2 (1)
|
2 (3)
|
<0.001
|
|
Chest radiograph D1, no quadrants
|
1 (1)
|
1 (1)
|
2 (2)
|
<0.001
|
|
Chest radiograph D2, no quadrants
|
0 (1)
|
2 (1)
|
2 (3)
|
<0.001
|
|
Chest radiograph D7, no quadrants
|
1 (0)
|
2 (1)
|
2 (1)
|
0.005
|
Berlin category
|
0
|
1
|
2
|
3
|
P-value
|
---|---|---|---|---|---|
N = 53
|
N = 9
|
N = 32
|
N = 7
|
||
ARDS risk factors on ICU admission
|
|||||
Sepsis
|
14 (26)
|
4 (44)
|
12 (38)
|
1 (14)
|
0.42
|
Shock
|
8 (15)
|
3 (33)
|
9 (28)
|
0
|
0.18
|
Trauma
|
11 (21)
|
0
|
2 (6)
|
0
|
0.09
|
General surgery
|
30 (57)
|
3 (33)
|
16 (50)
|
5 (71)
|
0.43
|
Vascular surgery
|
4 (8)
|
1 (1)
|
3 (9)
|
2 (29)
|
0.38
|
Cardiac surgery
|
3 (6)
|
0
|
2 (6)
|
1 (14)
|
0.69
|
Intracranial bleeding
|
10 (19)
|
2 (22)
|
1 (3)
|
1 (14)
|
0.19
|
CPR
|
6 (11)
|
1 (11)
|
2 (6)
|
1 (14)
|
0.86
|
Other
|
7 (13)
|
0
|
2 (6)
|
0
|
0.38
|
ARDS risk factors on D0
|
|||||
Sepsis
|
29 (56)
|
4 (44)
|
13 (41)
|
4 (57)
|
0.66
|
Shock
|
14 (26)
|
5 (56)
|
14 (44)
|
4 (57)
|
0.13
|
Pneumonia
|
3 (6)
|
0
|
4 (13)
|
2 (29)
|
0.14
|
Aspiration pneumonia
|
3 (6)
|
0
|
0
|
0
|
0.43
|
Peritonitis
|
3 (6)
|
1 (11)
|
1 (3)
|
0
|
0.71
|
Infected pancreatitis
|
2 (4)
|
0
|
1 (3)
|
0
|
0.89
|
Miscellaneous infection
|
20 (38)
|
2 (22)
|
10 (31)
|
3 (43)
|
0.75
|
Surgery within 48 hrs prior to inclusion
|
8 (15)
|
1 (11)
|
4 (13)
|
0
|
0.73
|
LIS category
|
LIS ≤1.0
|
LIS 1.0-2.5
|
LIS >2.5
|
P-value
|
|
N =14
|
N = 69
|
N =18
|
|||
ARDS risk factors on ICU admission
|
|||||
Sepsis
|
3 (21)
|
22 (32)
|
6 (33)
|
0.72
|
|
Shock
|
2 (14)
|
17 (25)
|
1 (6)
|
0.17
|
|
Trauma
|
1 (7)
|
10 (15)
|
2 (11)
|
0.73
|
|
General surgery
|
8 (57)
|
37 (54)
|
9 (50)
|
0.92
|
|
Vascular surgery
|
0
|
8 (11)
|
2 (11)
|
0.41
|
|
Cardiac surgery
|
0
|
4 (6)
|
2 (11)
|
0.42
|
|
Intracranial bleeding
|
5 (36)
|
7 (10)
|
2 (11)
|
0.04
|
|
CPR
|
1 (7)
|
7 (10)
|
2 (11)
|
0.93
|
|
Other
|
3 (21)
|
5 (7)
|
1 (6)
|
0.20
|
|
ARDS risk factors on D0
|
|||||
Sepsis
|
9 (64)
|
34 (49)
|
7 (39)
|
0.36
|
|
Shock
|
2 (14)
|
27 (39)
|
8 (44)
|
0.16
|
|
Pneumonia
|
1 (7)
|
6 (9)
|
2 (11)
|
0.92
|
|
Aspiration pneumonia
|
1 (7)
|
1 (2)
|
1 (6)
|
0.41
|
|
Peritonitis
|
1 (7)
|
3 (4)
|
1 (6)
|
0.90
|
|
Infected pancreatitis
|
2 (14)
|
1 (1)
|
0
|
0.03
|
|
Miscellaneous infection
|
7 (50)
|
25 (36)
|
3 (17)
|
0.13
|
|
Surgery within 48 hrs prior to inclusion
|
1 (7)
|
9 (13)
|
3 (17)
|
0.73
|
Association with ARDS severity
AUROC
|
95% CI
|
P-value
|
Optimal cutoff
|
SN
|
SP
|
PPV
|
NPV
|
|
---|---|---|---|---|---|---|---|---|
Maximum Berlin ≥1 (N = 59)
|
||||||||
Albumin
|
0.65
|
0.53-0.76
|
0.01
|
<20 g/L
|
71
|
58
|
71
|
58
|
Maximum Berlin ≥2 (N = 50)
|
||||||||
Albumin
|
0.63
|
0.52-0.74
|
0.02
|
<20 g/L
|
72
|
53
|
61
|
65
|
CRP
|
0.62
|
0.51-0.74
|
0.03
|
>138 mg/L
|
54
|
76
|
69
|
62
|
Maximum LIS >1.0 (N = 95)
|
||||||||
CRP
|
0.82
|
0.64-1.00
|
0.002
|
>81 mg/L
|
77
|
80
|
99
|
15
|
Maximum LIS >2.5 (N = 34)
|
||||||||
Albumin
|
0.62
|
0.51-0.73
|
0.04
|
<22 g/L
|
91
|
31
|
41
|
87
|
Monitoring ARDS severity
AUROC
|
95% CI
|
P-value
|
Optimal cutoff
|
SN
|
SP
|
PPV
|
NPV
|
||
---|---|---|---|---|---|---|---|---|---|
Berlin ≥1
|
day 0
|
||||||||
Albumin
|
0.62
|
0.52-0.72
|
0.03
|
<20 g/L
|
71
|
51
|
58
|
65
|
|
day 1
|
|||||||||
Albumin
|
0.66
|
0.56-0.77
|
0.003
|
<20 g/L
|
84
|
44
|
55
|
77
|
|
day 2
|
|||||||||
Albumin
|
0.67
|
0.56-0.78
|
0.002
|
<17 g/L
|
67
|
65
|
58
|
73
|
|
day 7
|
|||||||||
Albumin
|
0.71
|
0.59-0.81
|
<0.001
|
<14 g/L
|
38
|
92
|
81
|
63
|
|
Berlin ≥2
|
day 1
|
||||||||
Albumin
|
0.67
|
0.57-0.76
|
0.002
|
<18 g/L
|
73
|
54
|
44
|
80
|
|
day 2
|
|||||||||
Albumin
|
0.68
|
0.58-0.77
|
<0.001
|
<17 g/L
|
73
|
62
|
46
|
84
|
|
day 7
|
|||||||||
CRP
|
0.65
|
0.53-0.76
|
0.045
|
>105 mg/L
|
67
|
64
|
47
|
80
|
|
Berlin ≥3
|
day 7
|
||||||||
Albumin
|
0.77
|
0.65-0.86
|
0.01
|
<18 g/L
|
100
|
49
|
10
|
100
|
|
CRP
|
0.91
|
0.82-0.97
|
<0.001
|
>162 mg/L
|
100
|
73
|
19
|
100
|
|
LIS >1
|
day 0
|
||||||||
CRP
|
0.70
|
0.60-0.79
|
0.01
|
>81 mg/L
|
78
|
54
|
92
|
27
|
|
day 1
|
|||||||||
CRP
|
0.65
|
0.55-0.75
|
0.04
|
>182 mg/L
|
42
|
92
|
97
|
20
|
|
day 2
|
|||||||||
Albumin
|
0.82
|
0.73-0.89
|
<0.001
|
<21 g/L
|
86
|
64
|
94
|
43
|
|
day 7
|
|||||||||
Albumin
|
0.81
|
0.70-0.89
|
<0.001
|
<17 g/L
|
56
|
92
|
97
|
31
|
|
CRP
|
0.79
|
0.68-0.87
|
<0.001
|
>60 mg/L
|
68
|
79
|
93
|
36
|
|
LIS >2.5
|
day 1
|
||||||||
Albumin
|
0.69
|
0.56-0.78
|
0.02
|
<11 g/L
|
39
|
96
|
70
|
88
|
|
day 7
|
|||||||||
Albumin
|
0.72
|
0.60-0.82
|
0.004
|
<18 g/L
|
83
|
53
|
26
|
94
|
|
CRP
|
0.83
|
0.73-0.91
|
<0.001
|
>158 mg/L
|
75
|
80
|
41
|
94
|